Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 22 8 2018
medline: 19 9 2019
entrez: 22 8 2018
Statut: ppublish

Résumé

Papillon-Lefèvre syndrome (PLS) is characterized by nonfunctional neutrophil serine proteases (NSPs) and fulminant periodontal inflammation of unknown cause. Here we investigated neutrophil extracellular trap (NET)-associated aggregation and cytokine/chemokine-release/degradation by normal and NSP-deficient human and mouse granulocytes. Stimulated with solid or soluble NET inducers, normal neutrophils formed aggregates and both released and degraded cytokines/chemokines. With increasing cell density, proteolytic degradation outweighed release. Maximum output of cytokines/chemokines occurred mostly at densities between 2 × 10

Identifiants

pubmed: 30130433
doi: 10.1096/fj.201800752R
pmc: PMC6355082
doi:

Substances chimiques

Chemokines 0
Cytokines 0
Inflammation Mediators 0
Protease Inhibitors 0
Uric Acid 268B43MJ25
Ionomycin 56092-81-0
NADPH Oxidases EC 1.6.3.-
neutrophil cytosolic factor 1 EC 1.6.3.1
Tetradecanoylphorbol Acetate NI40JAQ945

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1401-1414

Références

Clin Cancer Res. 2016 Aug 1;22(15):3924-36
pubmed: 26957562
J Leukoc Biol. 2016 Aug;100(2):433-44
pubmed: 26957212
FASEB J. 2011 Feb;25(2):561-8
pubmed: 20959515
Front Immunol. 2013 Feb 20;4:38
pubmed: 23430963
Nat Med. 2016 Dec 6;22(12):1384-1386
pubmed: 27923022
Front Immunol. 2016 Nov 04;7:461
pubmed: 27867381
J Clin Invest. 2014 Oct;124(10):4539-48
pubmed: 25244098
Sci Transl Med. 2012 Oct 24;4(157):157ra141
pubmed: 23100627
J Cell Biol. 2007 Jan 15;176(2):231-41
pubmed: 17210947
Stain Technol. 1983 Nov;58(6):347-51
pubmed: 6679126
J Clin Invest. 2014 Oct;124(10):4237-9
pubmed: 25244092
Nature. 2014 Jun 5;510(7503):92-101
pubmed: 24899309
Immunol Rev. 2016 Sep;273(1):312-28
pubmed: 27558343
J Leukoc Biol. 2012 Oct;92(4):841-9
pubmed: 22802447
J Exp Med. 2010 Aug 30;207(9):1853-62
pubmed: 20733033
J Leukoc Biol. 2000 Feb;67(2):210-5
pubmed: 10670582
Nat Genet. 1999 Dec;23(4):421-4
pubmed: 10581027
Nat Commun. 2016 Jun 07;7:11596
pubmed: 27273006
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2817-22
pubmed: 25730848
Elife. 2017 Jun 02;6:
pubmed: 28574339
Immunol Rev. 2016 Sep;273(1):76-93
pubmed: 27558329
J Cell Biol. 2010 Nov 1;191(3):677-91
pubmed: 20974816
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1371-1379
pubmed: 28495931
J Emerg Med. 2007 Jan;32(1):23-6
pubmed: 17239729
Nature. 2013 Jun 20;498(7454):371-5
pubmed: 23708969
PLoS One. 2012;7(10):e46718
pubmed: 23056420
JCI Insight. 2017 May 18;2(10):
pubmed: 28515361
J Exp Med. 2002 Jun 3;195(11):1387-95
pubmed: 12045237
Cell Rep. 2016 Feb 2;14(4):708-722
pubmed: 26776523
PLoS Pathog. 2015 Mar 12;11(3):e1004651
pubmed: 25764063
J Mol Med (Berl). 2015 Jul;93(7):727-34
pubmed: 26002146
Allergol Int. 2017 Jul;66(3):463-471
pubmed: 28216055
Nat Biomed Eng. 2017;1:
pubmed: 29057147
Br J Pharmacol. 2009 Oct;158(4):1048-58
pubmed: 19845686
J Immunol. 2004 Dec 15;173(12):7277-81
pubmed: 15585850
JCI Insight. 2017 May 18;2(10):
pubmed: 28515366
Lancet Oncol. 2004 Mar;5(3):182-90
pubmed: 15003202
Nat Med. 2014 May;20(5):511-7
pubmed: 24784231
Cell Rep. 2018 Mar 13;22(11):2937-2950
pubmed: 29539422
Pediatr Pulmonol. 1999 Nov;28(5):363-75
pubmed: 10536068
PLoS One. 2013;8(1):e54205
pubmed: 23342104
J Leukoc Biol. 2013 Mar;93(3):427-35
pubmed: 23271700
Immunol Rev. 2017 Nov;280(1):26-40
pubmed: 29027227
Curr Allergy Asthma Rep. 2016 Jul;16(8):54
pubmed: 27393701
Anal Biochem. 2013 Nov 1;442(1):75-82
pubmed: 23911525
J Leukoc Biol. 1999 Feb;65(2):137-50
pubmed: 10088596
J Leukoc Biol. 2008 Jun;83(6):1309-22
pubmed: 18347074
J Immunol. 2005 Sep 1;175(5):3329-38
pubmed: 16116225
Front Immunol. 2014 Oct 21;5:508
pubmed: 25374568

Auteurs

Jonas Hahn (J)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Christine Schauer (C)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Christine Czegley (C)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Lasse Kling (L)

Max Planck Institute for the Science of Light, Erlangen, Germany.

Lenka Petru (L)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
Department of Rheumatology, First Faculty of Medicine, Charles University-Institute of Rheumatology, Prague, Czech Republic.

Benjamin Schmid (B)

Optical Imaging Centre Erlangen (OICE), Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Daniela Weidner (D)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Christiane Reinwald (C)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Mona H C Biermann (MHC)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Stefan Blunder (S)

Department of Dermatology, Venereology, and Allergology, Medical University of Innsbruck, Innsbruck, Austria.

Jürgen Ernst (J)

Fraunhofer Institute for Integrated Circuits (IIS), Erlangen, Germany.

Adam Lesner (A)

Faculty of Chemistry, University of Gdansk, Gdansk, Poland.

Tobias Bäuerle (T)

Institute of Radiology, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Ralf Palmisano (R)

Optical Imaging Centre Erlangen (OICE), Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Silke Christiansen (S)

Max Planck Institute for the Science of Light, Erlangen, Germany.
Helmholtz-Zentrum Berlin für Materialien und Energie, Berlin, Germany.
Physics Department, Freie Universität Berlin, Berlin, Germany.

Martin Herrmann (M)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Aline Bozec (A)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Robert Gruber (R)

Department of Dermatology, Venereology, and Allergology, Medical University of Innsbruck, Innsbruck, Austria.

Georg Schett (G)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Markus H Hoffmann (MH)

Department of Medicine 3, Friedrich Alexander University of Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH